SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
-------------
Date of report (Date of earliest event reported): July 7, 2000
LIFE TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 0-14991 34-0431300
(State of Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
9800 Medical Center Drive, Rockville, Maryland 20850
(Address of Principal Executive Offices) (Zip Code)
(301) 610-8000
(Registrant's telephone number, including area code)
<PAGE>
ITEM 5. OTHER EVENTS.
On July 9, 2000, Life Technologies, Inc. (the "Company") announced that it
signed a definitive agreement with Invitrogen Corporation ("Invitrogen")
providing for a merger of the Company into Invitrogen in which all of the
Company's outstanding shares of common stock will be converted into $60.00 per
share in cash and Invitrogen stock. A copy of the definitive merger agreement
between the Company and Invitrogen is filed as Exhibit 2.1 hereto.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
2.1 Agreement and Plan of Merger, dated as of July 7, 2000, between
Invitrogen Corporation and Life Technologies, Inc. Schedules and
similar attachments to this Exhibit may not have been filed; upon
request, the Company will furnish supplementally to the Commission
a copy of any omitted schedule.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LIFE TECHNOLOGIES, INC.
By: /s/ C. Eric Winzer
--------------------------------------
Name: C. Eric Winzer
Title: Vice President Finance &
Chief Financial Officer
Date: July 14, 2000
<PAGE>
EXHIBIT INDEX
Exhibit No. Exhibit Name Page Number
2.1 Agreement and Plan of Merger, dated as
of July 7, 2000, between Invitrogen
Corporation and Life Technologies, Inc.
Schedules and similar attachments to this
Exhibit may not have been filed; upon
request, the Company will furnish
supplementally to the Commission a copy of
any omitted schedule.
